We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Intervertebral Discs Bioengineered in the Laboratory

By LabMedica International staff writers
Posted on 29 Jan 2009
A new collaboration between U.S. physician-scientists has led to the creation of bioengineered intervertebral discs (IVDs) in the laboratory, for transplantation into the spines of rats.

Each year, 40-60% of adults suffer from chronic back pain in the United States alone. For patients diagnosed with severe degenerative disc disease, neurosurgeons must perform surgery called discectomy--removing the IVD--followed by a fusion of the vertebrate bones to stabilize the spine. Even after all that effort, the patient's back, in all probability, will not feel the same as before their injury.

To create new spine discs, Drs. Roger Härtl and Lawrence Bonassar from Weill Cornell Medical College (New York, NY, USA) and basic science researchers at Cornell University (Ithaca, NY, USA) are using cells from IVD tissue of human patients who have had their spinal discs removed. Dr. Härtl is a well-known neurologic surgeon at New York-Presbyterian Hospital/Weill Cornell Medical Center (New York, NY, USA), and assistant professor of neurological surgery at Weill Cornell Medical College, and Dr. Bonassar is an associate professor in the departments of biomedical engineering and mechanical and aerospace engineering at Cornell University.

In the process, Dr. Härtl harvests tissue from the removed discs and sends it to Dr. Bonassar. Cells are then isolated from this tissue and grown in an incubator that simulates the environment in the body. Once developed, they are placed on a bioengineered scaffold, enabling the assembly of the cells and scaffold into an IVD-shaped implant. The researchers then surgically implant the discs inside a rat's spine in order to see how the tissue reacts to the mechanical and biologic demands. So far, results are promising.

The researchers hope to soon evaluate the bioengineered discs in human subjects in a clinical trial, so that someday individuals can receive spare parts for their aging or injured backs.

Related Links:
Weill Cornell Medical College


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Electrolyte Analyzer
BKE-B
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma

Latest BioResearch News

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
29 Jan 2009  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
29 Jan 2009  |   BioResearch

New Immune Target Could Support More Precise High Blood Pressure Treatment
29 Jan 2009  |   BioResearch